News
EHC
98.91
-0.55%
-0.55
EHC December 2025 Options Begin Trading
NASDAQ · 1d ago
Peering Into Encompass Health's Recent Short Interest
Benzinga · 2d ago
Encompass Health Price Target Raised to $110.00/Share From $105.00 by RBC Capital
Dow Jones · 3d ago
Encompass Health Is Maintained at Outperform by RBC Capital
Dow Jones · 3d ago
RBC Capital Maintains Outperform on Encompass Health, Raises Price Target to $110
Benzinga · 3d ago
Encompass Health Price Target Raised to $116.00/Share From $108.00 by Truist Securities
Dow Jones · 3d ago
Truist Securities Reiterates Buy on Encompass Health, Raises Price Target to $116
Benzinga · 3d ago
Encompass Health price target raised to $116 from $108 at Truist
TipRanks · 3d ago
RBC Capital Reaffirms Their Buy Rating on Encompass Health (EHC)
TipRanks · 3d ago
Encompass Health Reports Strong Q3 2024 Results
TipRanks · 4d ago
Cannabis Stock Movers For October 29, 2024
Benzinga · 4d ago
Encompass Health Up Over 6%, On Pace for Highest Close Since July 1998 -- Data Talk
Dow Jones · 4d ago
Bank of America Securities Keeps Their Buy Rating on Encompass Health (EHC)
TipRanks · 4d ago
Breaking Down Encompass Health: 10 Analysts Share Their Views
Benzinga · 4d ago
Encompass Health Is Maintained at Overweight by Barclays
Dow Jones · 4d ago
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $116
Benzinga · 4d ago
Analysts Offer Insights on Healthcare Companies: Humana (HUM), Encompass Health (EHC) and Amgen (AMGN)
TipRanks · 4d ago
Encompass Health’s Strong Q3 Performance and Upward Guidance Justify Buy Rating
TipRanks · 4d ago
Encompass Health Is Maintained at Overweight by Keybanc
Dow Jones · 4d ago
Encompass Health’s Strong Q3 Performance and Raised 2024 Guidance Drive Buy Rating
TipRanks · 4d ago
More
Webull provides a variety of real-time EHC stock news. You can receive the latest news about Encompass Health Corp through multiple platforms. This information may help you make smarter investment decisions.
About EHC
Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides specialized rehabilitative treatment on an inpatient basis. It operates hospitals in 37 states and Puerto Rico, with concentrations in Florida and Texas. It operates 161 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. The Company provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals also treat patients with or recovering from the COVID-19 virus. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.